Cargando…

New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells

BACKGROUND: Colorectal carcinoma is one of the major causes of morbidity and mortality in the Western World. Novel therapeutic approaches are needed for colorectal carcinoma. Curcumin, the active component and yellow pigment of turmeric, has been reported to have several anti-cancer activities inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cen, Ling, Hutzen, Brian, Ball, Sarah, DeAngelis, Stephanie, Chen, Chun-Liang, Fuchs, James R, Li, Chenglong, Li, Pui-Kai, Lin, Jiayuh
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674881/ https://www.ncbi.nlm.nih.gov/pubmed/19331692 http://dx.doi.org/10.1186/1471-2407-9-99

Ejemplares similares

A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells
por: Lin, Li, et al.
Publicado: (2010)

Dietary agent, benzyl isothiocyanate inhibits signal transducer and activator of transcription 3 phosphorylation and collaborates with sulforaphane in the growth suppression of PANC-1 cancer cells
por: Hutzen, Brian, et al.
Publicado: (2009)

The curcumin analogue hydrazinocurcumin exhibits potent suppressive activity on carcinogenicity of breast cancer cells via STAT3 inhibition
por: WANG, XIAOFEI, et al.
Publicado: (2011)

The Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Induces Apoptosis in Medulloblastoma and Glioblastoma Cells
por: Ball, Sarah, et al.
Publicado: (2011)

Curcumin analogue BDDD-721 exhibits more potent anticancer effects than curcumin on medulloblastoma by targeting Shh/Gli1 signaling pathway
por: Gong, Weiyi, et al.
Publicado: (2022)

Curcumin analogue T83 exhibits potent antitumor activity and induces radiosensitivity through inactivation of Jab1 in nasopharyngeal carcinoma
por: Pan, Yunbao, et al.
Publicado: (2013)

The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines
por: Fossey, Stacey L, et al.
Publicado: (2011)

Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells
por: Lin, Li, et al.
Publicado: (2013)

Folate Decorated Nanomicelles Loaded with a Potent Curcumin Analogue for Targeting Retinoblastoma
por: Alsaab, Hashem, et al.
Publicado: (2017)

The curcumin analogue PAC has potent anti-anaplastic thyroid cancer effects
por: Al-Mohanna, Mai, et al.
Publicado: (2023)

Structurally Modified Curcumin Analogs Inhibit STAT3 Phosphorylation and Promote Apoptosis of Human Renal Cell Carcinoma and Melanoma Cell Lines
por: Bill, Matthew A., et al.
Publicado: (2012)

Demethoxycurcumin analogue DMC-BH exhibits potent anticancer effects on orthotopic glioblastomas
por: Shi, Lei, et al.
Publicado: (2020)

Monocarbonyl Curcumin Analogues as Potent Inhibitors against Human Glutathione Transferase P1-1
por: Pantiora, Panagiota, et al.
Publicado: (2022)

LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model
por: Fuh, B, et al.
Publicado: (2009)

Targeting colorectal cancer stem cells using curcumin and curcumin analogues: insights into the mechanism of the therapeutic efficacy
por: Ramasamy, Thamil Selvee, et al.
Publicado: (2015)

STAT3 as a potential therapeutic target in ALDH(+) and CD44(+)/CD24(+) stem cell-like pancreatic cancer cells
por: Lin, Li, et al.
Publicado: (2016)

The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity
por: Bill, Matthew A, et al.
Publicado: (2010)

Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival
por: Chen, Chun-Liang, et al.
Publicado: (2008)

Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-κB
por: Chen, Jian, et al.
Publicado: (2017)

STAT3 can be activated through paracrine signaling in breast epithelial cells
por: Lieblein, Jacqueline C, et al.
Publicado: (2008)

Corrigendum to “Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-κB”
por: Chen, Jian, et al.
Publicado: (2017)

Cholangiocarcinoma cells secrete soluble factors that activate Jak/STAT signal transduction and promote MDSC expansion
por: Yang, Jennifer, et al.
Publicado: (2014)

Curcumin in Health and Diseases: Alzheimer’s Disease and Curcumin Analogues, Derivatives, and Hybrids
por: Chainoglou, Eirini, et al.
Publicado: (2020)

Potent anti-cancer effects of less polar Curcumin analogues on gastric adenocarcinoma and esophageal squamous cell carcinoma cells
por: Alibeiki, Fatemeh, et al.
Publicado: (2017)

LLL12B, a Novel Small-Molecule STAT3 Inhibitor, Induces Apoptosis and Suppresses Cell Migration and Tumor Growth in Triple-Negative Breast Cancer Cells
por: Pan, Li, et al.
Publicado: (2022)

MI-63: A novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53
por: Canner, J A, et al.
Publicado: (2009)

An insight into the in vivo imaging potential of curcumin analogues as fluorescence probes
por: Liu, Yu, et al.
Publicado: (2021)

Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030
por: Lin, L, et al.
Publicado: (2011)

FM807, a curcumin analogue, shows potent antitumor effects in nasopharyngeal carcinoma cells by heat shock protein 90 inhibition
por: Ye, Min, et al.
Publicado: (2017)

Molecular docking analysis of curcumin analogues with COX-2
por: Sohilait, Mario Rowan, et al.
Publicado: (2017)

Molecular Pathways Modulated by Curcumin Analogue, Diarylpentanoids in Cancer
por: Paulraj, Felicia, et al.
Publicado: (2019)

Combination treatment with highly bioavailable curcumin and NQO1 inhibitor exhibits potent antitumor effects on esophageal squamous cell carcinoma
por: Mizumoto, Ayaka, et al.
Publicado: (2019)

Bazedoxifene exhibits growth suppressive activity by targeting interleukin‐6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma
por: Ma, Haiyan, et al.
Publicado: (2019)

SUN-196 Generation of Potent Inhibin Analogues
por: Goney, Monica, et al.
Publicado: (2019)

Design and Synthesis of Novel Dehydroepiandrosterone Analogues as Potent Antiproliferative Agents
por: Huang, Xing, et al.
Publicado: (2018)

The Anti-Cancer Effect of Four Curcumin Analogues on Human Glioma Cells
por: Luo, Siou-Min, et al.
Publicado: (2021)

Curcumin analogues exert potent inhibition on human and rat gonadal 3β-hydroxysteroid dehydrogenases as potential therapeutic agents: structure-activity relationship and in silico docking
por: Qiao, Xinyi, et al.
Publicado: (2023)

Design and synthesis of novel oridonin analogues as potent anticancer agents
por: Shen, Qing-Kun, et al.
Publicado: (2018)

Monocytes from infliximab-resistant patients with Crohn’s disease exhibit a disordered cytokine profile
por: Gaiani, Federica, et al.
Publicado: (2020)

Robenidine Analogues Are Potent Antimalarials in Drug-Resistant Plasmodium falciparum
por: Krollenbrock, Alina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k9frg15ut3s5j7srkdof7jr1kt